English
FranįaisObbligazione BioMarin Pharmaceutical 5.5% ( US09061GAL59 ) in USD
| Emittente | BioMarin Pharmaceutical | ||||||
| Prezzo di mercato |  100.00 USD ⇌ |
||||||
| Paese |  Stati Uniti
|
||||||
| Codice isin |
 US09061GAL59 ( in USD )
|
||||||
| Tasso d'interesse | 5.5% per anno ( pagato 2 volte l'anno) | ||||||
| Scadenza | 15/02/2034 | ||||||
|
La brochure del prospetto in formato PDF |
|||||||
| Importo minimo | 200 000 USD | ||||||
| Importo totale | 850 000 000 USD | ||||||
| Cusip | 09061GAL5 | ||||||
| Standard & Poor's ( S&P ) rating | BB ( Non-investment grade speculative ) | ||||||
| Moody's rating | Ba3 ( Non-investment grade speculative ) | ||||||
| Coupon successivo | 15/02/2027 ( In 173 giorni ) | ||||||
| Descrizione dettagliata |
Azienda biotecnologica americana specializzata in terapie per malattie genetiche rare. The Obbligazione issued by BioMarin Pharmaceutical ( United States ) , in USD, with the ISIN code US09061GAL59, pays a coupon of 5.5% per year. The coupons are paid 2 times per year and the Obbligazione maturity is 15/02/2034 The Obbligazione issued by BioMarin Pharmaceutical ( United States ) , in USD, with the ISIN code US09061GAL59, was rated Ba3 ( Non-investment grade speculative ) by Moody's credit rating agency. The Obbligazione issued by BioMarin Pharmaceutical ( United States ) , in USD, with the ISIN code US09061GAL59, was rated BB ( Non-investment grade speculative ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||
| |||||||